 |
Effects
of high-fat diet exposure during fetal life on type 2 diabetes
development in the progeny |
| |
We conclude that a HF diet during fetal life,
particularly if combined with the same insult during the suckling
period, can induce the type 2 diabetes phenotype, which can be
directly transmitted to the progeny even in the absence of additional
dietary insults (Journal of Lipid Research) |
| |
|
|
Joslin
Study Identifies Protein that Produces ‘Good’ Fat |
| |
A study by researchers at the Joslin Diabetes
Center has shown that a protein known for its role in inducing
bone growth can also help promote the development of brown fat,
a “good” fat that helps in the expenditure of energy and plays a role in fighting obesity
(Joslin Diabetes Center) |
| |
|
|
Cymbalta
reduces diabetics' DPNP for over six months |
| |
Eli Lilly and partner Boehringer Ingelheim say
that treatment with the blockbuster Cymbalta, which is approved
as an antidepressant and painkiller, reduces diabetic peripheral
neuropathic pain for more than six months (Pharma Times) |
| |
|
|
Diabetes
Research Network hoping for online recruitment boost |
| |
A recent report by market analyst Datamonitor
suggested that web-based tools were the key to overcoming the recruitment
drought in the established markets for clinical research. At the
end of May the UKDRN launched a new website and DVD, coinciding
with International Clinical Trials Day, that it hopes will achieve
just that effect for diabetes research (Pharma Times) |
| |
|
|
Therapeutic
approach of type 2 diabetes mellitus with GLP-1 based therapies |
| |
In patients with T2DM inadequately controlled
with maximal tolerated oral multi-therapies, GLP-1 agonists are
a good alternative to insulin therapy, allowing reaching a better
glycaemic control together with a weight loss (PubMed) |
| |
|
|
Pharmacologic
Management in Pediatric Type 1 Diabetes Mellitus |
| |
Pharmacists can play a major role in optimizing
insulin drug regimens, selecting the most appropriate insulin,
and counseling for adverse effects. Future studies are necessary
to determine whether noninsulin therapies are effective for the
treatment of T1DM. Insulin pump therapy is becoming more favorable
(U.S. Pharmacist ) |
| |
|
|
FDA
approves Home Diagnostic diabetes test |
| |
Home Diagnostics Inc. said Tuesday it received
U.S. approval to market a portable blood-sugar testing device for
diabetes patients (Business Week) |
| |
|
|
Diabetic
threesome (hyperglycaemia, renal function and nutrition) and
advanced glycation end products: evidence for the multiple-hit
agent? |
| |
Inter-individual genetic and functional variability
in genes encoding enzymes and receptors involved in either the
formation or the degradation of AGE could have important pathogenic,
nutrigenomic and nutrigenetic consequences (PubMed) |
| |
|
|
Growing
economic cost of obesity in 2008 |
| |
The report titled “Growing
economic costs of obesity in 2008” reveals that there has been a 137% increase since 2005 in the number of Australians
who have type 2 diabetes as a result of being obese (Diabetes Australia) |
| |
|
|
Amylin
Pharmaceuticals Diabetes Drug Byetta(R) the Focus of California
Lawsuit |
| |
A Virginia man yesterday filed what is believed
to be the first personal injury lawsuit stemming from injuries
associated with the use of Byetta(R), an injectable medication
for diabetes (Centre Daily) |
| |
|
